CME
![](https://www.oncolens.com/wp-content/uploads/2024/02/peerview-quality-improvement-1200x675-logo.jpg)
Hitting the Benchmarks in mCRC: A Precision Medicine Quality Initiative for the Care Team
0.75 CME/MOC/CC/NCPD/CPE/AAPA/IPCE
Topics — PeerView
![](https://www.oncolens.com/wp-content/uploads/2024/02/vindico-medical-education-1200x675-logo.jpg)
Melanoma Oncolytic Immunotherapy: An Evolving Therapeutic Landscape
Maximum of 1.25 AMA PRA Category 1 Credit(s)™.
![](https://www.oncolens.com/wp-content/uploads/2024/02/project-echo-ptce-website-logo.jpg)
Project ECHO® Learning Series: Evolving Role of Bispecific Antibodies as Cancer Therapy
These activities will be CME/CPE/CNE-certified.
![](/wp-content/themes/yootheme/cache/99/webinar-irAE-2022-powered-by-oncolens-9928bc81.jpeg)
Project ECHO®: Pulmonary Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in May 2023
![](/wp-content/themes/yootheme/cache/99/webinar-irAE-2022-powered-by-oncolens-9928bc81.jpeg)
Project ECHO®: Dermatologic Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in April 2023
![](/wp-content/themes/yootheme/cache/99/webinar-irAE-2022-powered-by-oncolens-9928bc81.jpeg)
Project ECHO®: Hepatobiliary Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in March 2023
![](/wp-content/themes/yootheme/cache/99/webinar-irAE-2022-powered-by-oncolens-9928bc81.jpeg)
Project ECHO®: Neurological Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in February 2023
![](/wp-content/themes/yootheme/cache/99/webinar-irAE-2022-powered-by-oncolens-9928bc81.jpeg)
Project ECHO®: Rheumatologic Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in January 2023
![](/wp-content/themes/yootheme/cache/99/webinar-irAE-2022-powered-by-oncolens-9928bc81.jpeg)
Project ECHO®: Endocrine Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in November 2022
![](/wp-content/themes/yootheme/cache/99/webinar-irAE-2022-powered-by-oncolens-9928bc81.jpeg)
Project ECHO®: Gastroenterology Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in October 2022
![](/wp-content/themes/yootheme/cache/99/webinar-irAE-2022-powered-by-oncolens-9928bc81.jpeg)
Project ECHO®: Cardiovascular Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in September 2022
![](/wp-content/themes/yootheme/cache/99/webinar-irAE-2022-powered-by-oncolens-9928bc81.jpeg)
Project ECHO® Learning Series: Telementoring to Manage Immune-Related Adverse Events in Patients Receiving Cancer Immunotherapies
These activities will be CME/CPE/CNE-certified.
![Optimizing Frontline Immunotherapy in Advanced Non-Small Cell Lung Cancer: Program Highlights](https://www.oncolens.com/wp-content/uploads/2022/05/rmei-non-small-cell-cancer-immunotherapy-highlights.jpg)
Optimizing Frontline Immunotherapy in Advanced Non-Small Cell Lung Cancer
Physician: .75 AMA PRA Category 1 Credit(s)™
Topics — NSCLC
![Molecular testing in the community oncology setting](https://www.oncolens.com/wp-content/uploads/2021/06/cme-molecular-testing-in-the-community-oncology-setting.jpg)
Molecular Testing in the Community Oncology Setting
Content Derived from a CME Certified Webinar in June 2021